ACL Tear Clinical Trial
Official title:
A Randomized, Single Blinded Study of the Augmentation of Anterior Cruciate Ligament Reconstruction Using Stump-Derived Mesenchymal Stem Cells Versus Standard of Care Anterior Cruciate Ligament Reconstruction
The goal of this observational study is to compare patient outcomes for reconstructive surgery of ACL tears. This study utilizes two randomized groups, one being the control group that receives standard ACL reconstructive surgery, while the other is the test group at will receive an injection of stem cells taken from elsewhere within the body. The main objectives are to determine the usefulness of stem cells as a cost-effective implant in reconstructive surgery and to determine if the stem cells provide more optimized healing outcomes. Participants will: - Receive ACL reconstructive surgery as normal - One-half of the participants will receive stem cells at the repair site as the test group - All participants will have 3, 6, 9, 12, 18, and 24 month followups to chart their recovery progress Thus, the outcomes of the group receiving stem cell injections will be compared directly with the outcomes of the standard ACL reconstructive care group.
The primary objective of this study is to develop a cost-effective, autologous biologic augmentation technique for ACL reconstruction. The technique involves encasing MSCs harvested from the patient's ACL stump tissue with the GraftNet device in a porous bovine collagen matrix carrier around the ACL autograft. This study is key to determining a reproducible and effective autologous biologic augmentation technique that can be utilized at the point-of-care during ACL reconstruction surgery. FTA results as well as measurements from MRI evaluation will be recorded and utilized to quantify the healing and ACL graft maturation processes. MRI evaluation will be performed in accordance with accepted ACL imaging protocols. This data will then be compared to FTA results and MRI evaluation from patients who did not undergo the bioaugmentation technique for ACL reconstruction. Study design will be a prospective, blinded randomized, single center trial. Patients at the Andrews Institute who meet the inclusion criteria will have the study explained in detail and informed consent will be obtained as outlined below. Fifty patients will be blinded, randomized, and undergo a Bone-Patellar Tendon-Bone (BTB) ACL reconstruction surgery. Twenty-Five randomized patients will receive standard of care (SOC) BTB ACL reconstruction surgery. Twenty-Five randomized patients will receive BTB ACL reconstruction surgery augmented with the patient's ACL stump tissue harvested with the GraftNet device and a porous bovine collagen matrix carrier around the ACL autograft. At each follow up visit after ACL reconstruction, patient reported outcome measures (PROMs) will be collected by the research team to assist in assessing the overall health and rehabilitation of each participant. The following patient reported outcomes will be collected in written or electronic format after informed consent has been obtained from each participant:Tampa Scale of Kinesiophobia, International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC), Patient Reported Outcome Measurements Information System (PROMIS), Single Assessment Numeric Evaluation (SANE), and Magnetic Resonance Imaging (MRI). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02450292 -
Retrospective CT Imaging of BioComposite Interference Screw With BTB
|
||
Recruiting |
NCT05912777 -
3D Reconstruction of the Knee Based on MRI
|
N/A | |
Recruiting |
NCT04058574 -
Proprioceptive Isokinetic Repositioning, Functional Testing, and a Self-reported Questionnaire Before and After Anterior Cruciate Ligament Reconstruction
|
N/A | |
Recruiting |
NCT06430775 -
Exploring Prolonged AMR in ACL Reconstructed Patients
|
||
Recruiting |
NCT06274008 -
Exparel vs. ACB With Bupivacaine for ACL Reconstruction
|
Phase 1 | |
Recruiting |
NCT06096259 -
Preventing Injured Knees From osteoArthritis: Severity Outcomes
|
Phase 2 | |
Active, not recruiting |
NCT05338385 -
Readiness Outcomes Affecting Return to Sport 2.0: An Intervention Feasibility & Pilot Study
|
N/A | |
Enrolling by invitation |
NCT05931627 -
Tourniquet Use in Anterior Cruciate Ligament Repair
|
N/A | |
Not yet recruiting |
NCT06340932 -
Impact of Opioid Avoidance Protocol for ACL Reconstruction
|
||
Completed |
NCT04484961 -
Effects of Blood Flow Restriction Rehabilitation After Anterior Cruciate Ligament Reconstruction
|
N/A | |
Completed |
NCT05876013 -
Reduced Knee Flexion Strength 18 Years After ACL Reconstruction in Hamstring Group Compared to Patellar Tendon Group
|
||
Active, not recruiting |
NCT04748328 -
Comparison Effectiveness Analysis Between ACL Reconstruction and Rehabilitation in Peripheral and Main Capital in Indonesia
|
||
Recruiting |
NCT04732585 -
Kinematic Assessment of Human Peripheral Joints by Dynamic CT
|
N/A | |
Completed |
NCT03243162 -
Improving ACL Reconstruction Outcomes: CBPT
|
N/A | |
Recruiting |
NCT06235736 -
Do Patients With ACL Tears Demonstrate Weakness of the Soleus Muscle?
|
||
Not yet recruiting |
NCT06063915 -
Isoinertial Rehabilitation in Recovering Hamstring Strength Following Surgical Anterior Cruciate Ligament Reconstruction
|
N/A | |
Recruiting |
NCT04550299 -
ACL Reconstruction With Simple and Double Bundle Technique Using Two Different Implants for Graft Fixation
|
N/A | |
Not yet recruiting |
NCT04721119 -
Comparing Adductor Canal Block and Adductor Canal Block-Local Infiltration Analgesia for Post-operative Pain Management
|
N/A | |
Completed |
NCT04827264 -
Safe Return to Play After ACL Reconstruction
|
||
Recruiting |
NCT04682392 -
ACL Bone Health and Loading Study
|
N/A |